Anti Tissue Transglutaminase IgG Test at Lahore PCR Lab

Anti Tissue Transglutaminase IgG at Lahore PCR Lab

The Anti Tissue Transglutaminase IgG (tTG IgG) test is a highly specialized serological assay utilized primarily in the diagnostic workup of celiac disease, a systemic autoimmune disorder triggered by the ingestion of gluten in genetically susceptible individuals. Tissue transglutaminase is a calcium-dependent enzyme found intracellularly and extracellularly in various tissues, particularly within the mucosal layer of the small intestine. In patients with celiac disease, the immune system mistakenly identifies this enzyme as a foreign threat, generating autoantibodies against it. While the IgA isotype of anti-tTG is the primary screening tool due to its superior sensitivity and specificity in the general population, the IgG isotype serves as an indispensable diagnostic alternative. Specifically, in patients who suffer from selective immunoglobulin A (IgA) deficiency—a condition that is statistically ten to fifteen times more prevalent among celiac patients than the general population—the standard IgA-based tests will yield false-negative results. In these clinical scenarios, measuring the Anti-tTG IgG antibody levels provides a highly reliable, evidence-based pathway to establish an accurate diagnosis.

At Lahore PCR Lab, located in the heart of Lahore, Pakistan, this advanced immunological investigation is performed using state-of-the-art automated immunoassay platforms. The test evaluates the presence and concentration of IgG autoantibodies directed against tissue transglutaminase in the patient’s blood serum. By analyzing these immunological markers, the laboratory provides clinicians with crucial diagnostic data that directly correlates with the degree of gluten-induced enteropathy. The primary anatomical structure evaluated indirectly through this serological marker is the small intestine, specifically the duodenum, where gluten-induced inflammation leads to progressive villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. Understanding the physiological impact of celiac disease is vital, as untreated gluten-sensitive enteropathy can lead to severe malabsorption, nutritional deficiencies, osteoporosis, and an increased risk of intestinal malignancies. The diagnostic value of the Anti-tTG IgG test at Lahore PCR Lab lies in its ability to non-invasively identify celiac disease in high-risk or IgA-deficient patients, thereby guiding the clinical decision-making process regarding the necessity of an upper gastrointestinal endoscopy and duodenal biopsy.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is paramount to ensure the clinical accuracy and diagnostic validity of the Anti-Tissue Transglutaminase IgG test. Patients must adhere to the following guidelines prior to sample collection:

• Maintain a Gluten-Containing Diet: The most critical preparation requirement is that the patient must continue to consume a normal, gluten-containing diet (including wheat, barley, and rye) for at least six to eight weeks prior to the blood draw. Eliminating or significantly reducing gluten intake before the test can cause antibody levels to decline rapidly, potentially leading to a false-negative result that masks active disease.
• No Fasting Required: Standard fasting is generally not mandatory for this specific serological test. Patients may eat and drink normally, provided no other concurrent blood tests require fasting.
• Medication Disclosure: Patients must inform their referring physician and the laboratory staff at Lahore PCR Lab of any immunosuppressive medications, systemic corticosteroids, or chemotherapy they are currently receiving, as these therapies can suppress antibody production and affect test outcomes.
• Hydration: Adequate hydration is recommended before the procedure to facilitate easier venipuncture.

During the Procedure

The collection of the blood sample at Lahore PCR Lab is a quick, sterile, and routine phlebotomy procedure executed by highly trained professionals:

• Patient Positioning: The patient is comfortably seated in a specialized phlebotomy chair, and the arm is positioned to expose the antecubital fossa (the inner bend of the elbow).
• Site Selection and Sanitization: The phlebotomist palpates the arm to locate a suitable vein, typically the median cubital vein. The selected area is thoroughly sanitized using a 70% isopropyl alcohol swab to prevent contamination.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube system (specifically a gold-top serum separator tube or a red-top clot activator tube) is gently inserted into the vein.
• Sample Collection: Approximately 3 to 5 milliliters of blood are drawn into the tube. The tourniquet, which was temporarily applied to increase venous pressure, is released once blood flow is established.
• Post-Collection Care: The needle is smoothly withdrawn, and immediate manual pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then applied.
• Duration and Safety: The entire process takes less than five minutes. It is highly safe, with minimal risks limited to localized bruising, mild transient discomfort at the needle insertion site, or very rarely, lightheadedness.

When is an Anti Tissue Transglutaminase IgG Test Performed?

Diagnosis of Celiac Disease in IgA-Deficient Patients

Physicians request the Anti-tTG IgG test when a patient exhibits classic symptoms of celiac disease but has been diagnosed with selective IgA deficiency. Because standard screening relies heavily on IgA-class antibodies, patients lacking sufficient total serum IgA cannot produce detectable levels of anti-tTG IgA, even in the presence of severe gluten-induced mucosal damage. In such cases, the IgG-based assay is the clinically indicated gold standard to prevent missed diagnoses and ensure that celiac enteropathy is accurately identified.

Investigation of Chronic Gastrointestinal Symptoms

This test is frequently ordered for patients presenting with persistent, unexplained gastrointestinal distress. Symptoms such as chronic diarrhea, steatorrhea (foul-smelling, fatty stools), recurrent abdominal pain, bloating, flatulence, and unexplained weight loss warrant comprehensive serological evaluation. The test helps clinicians differentiate between celiac disease, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and non-celiac gluten sensitivity, allowing for targeted therapeutic interventions.

Evaluation of Unexplained Malabsorption and Nutritional Deficiencies

When patients present with signs of systemic malabsorption, the Anti-tTG IgG test is a vital diagnostic component. Clinical indicators include refractory iron-deficiency anemia that does not respond to oral iron supplementation, unexplained vitamin D deficiency, early-onset osteoporosis or osteopenia in young adults, and failure to thrive or short stature in pediatric patients. By identifying underlying celiac disease, the test addresses the root cause of mucosal damage that impairs nutrient absorption in the small intestine.

Screening High-Risk and Autoimmune Populations

Due to the strong genetic association of celiac disease with specific HLA haplotypes and other autoimmune conditions, screening is highly recommended for asymptomatic individuals in high-risk categories. This includes first-degree relatives of diagnosed celiac patients, as well as individuals with Type 1 Diabetes Mellitus, autoimmune thyroiditis (Hashimoto’s thyroiditis), Down syndrome, Turner syndrome, and Williams syndrome. Early detection through serology helps prevent long-term complications associated with silent celiac disease.

Monitoring Adherence to a Gluten-Free Diet

In patients previously diagnosed with celiac disease who also have a co-existing IgA deficiency, the Anti-tTG IgG test is utilized as a non-invasive monitoring tool. Over time, strict adherence to a gluten-free diet (GFD) should result in a gradual decline of IgG antibody titers. Persistently elevated or rising levels of Anti-tTG IgG during follow-up evaluations indicate ongoing gluten exposure, whether accidental or intentional, requiring dietary counseling and further clinical review.

What Does an Anti Tissue Transglutaminase IgG Test Detect?

The Anti-Tissue Transglutaminase IgG test at Lahore PCR Lab is designed to detect and quantify specific immunological markers and clinical states related to gluten sensitivity. The test provides critical diagnostic insights by identifying the following:

• Elevated IgG Autoantibodies: Detects high levels of IgG antibodies directed against tissue transglutaminase, strongly indicating active celiac disease in IgA-deficient individuals.
• Selective IgA Deficiency Correlation: Helps confirm celiac disease when paired with a low total serum IgA test, preventing false-negative screening outcomes.
• Gluten-Induced Enteropathy: Indirectly detects the presence of active, immune-mediated damage to the small intestinal mucosa.
• Dermatitis Herpetiformis Association: Aids in diagnosing the cutaneous manifestation of celiac disease, characterized by intensely itchy, blistering skin rashes.
• Dietary Non-Compliance: Detects persistent gluten ingestion in diagnosed celiac patients who should be maintaining a strict gluten-free diet.
• Accidental Gluten Exposure: Identifies hidden gluten consumption in patients who believe they are adhering to dietary restrictions but are experiencing ongoing mucosal inflammation.
• Seronegative Celiac Disease Context: Helps rule out or raise suspicion of celiac disease in complex clinical cases where other serological markers are equivocal.
• Pediatric Celiac Disease: Detects autoimmune gluten sensitivity in symptomatic children, facilitating early intervention to prevent growth retardation.
• Atypical Celiac Disease: Identifies celiac disease in patients presenting with extraintestinal symptoms rather than classic gastrointestinal complaints.
• Silent Celiac Disease: Detects active autoimmune responses in completely asymptomatic individuals belonging to high-risk groups.
• Refractory Celiac Disease Assessment: Assists in evaluating patients who do not clinically improve despite a gluten-free diet, helping to differentiate between dietary non-compliance and refractory celiac disease.
• Autoimmune Hepatitis Association: Detects elevated titers that can sometimes co-occur in patients with autoimmune liver diseases, requiring careful clinical correlation.
• Risk of Malabsorption: High antibody titers correlate with a greater likelihood of severe villous atrophy, which directly increases the risk of malabsorption-related complications.
• Potential for Mucosal Healing: Normalizing antibody levels over successive tests detects successful mucosal recovery and therapeutic response.
• Need for Duodenal Biopsy: A highly positive result detects a clear clinical indication for confirmatory upper gastrointestinal endoscopy and tissue biopsy.
• Unexplained Transaminitis: Helps identify celiac disease as the underlying cause of unexplained elevations in liver enzymes (AST and ALT).
• Neurological Manifestations Link: Aids in investigating gluten ataxia or peripheral neuropathy of unknown origin by confirming systemic gluten sensitivity.
• Infertility and Obstetric Complications: Detects undiagnosed celiac disease in women experiencing unexplained infertility, recurrent miscarriages, or low birth weight infants.
• Dental Enamel Defects: Helps link severe, unexplained dental enamel hypoplasia in children to early-onset, undiagnosed celiac disease.
• Aphthous Stomatitis Link: Identifies gluten sensitivity in patients suffering from severe, recurrent canker sores in the oral cavity.

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab is dedicated to providing rapid, accurate, and highly reliable diagnostic services to patients and healthcare providers across Lahore. Utilizing advanced, fully automated immunoassay analyzers, the laboratory ensures that the Anti-Tissue Transglutaminase IgG test is processed under strict quality control protocols. The standard turnaround time for this specialized serological investigation is typically within 24 to 48 hours from the time of sample collection. Once the analysis is complete, the results are meticulously reviewed and validated by a Consultant Pathologist to ensure clinical accuracy. Patients are promptly notified via SMS when their reports are ready. Reports can be accessed and downloaded securely online through the official Lahore PCR Lab web portal, eliminating the need for a physical visit. For convenience, physical copies of the reports are also available for collection at the main laboratory facility and designated collection centers across the city.

Anti Tissue Transglutaminase IgG Findings Overview

The interpretation of the Anti-Tissue Transglutaminase IgG test requires a comprehensive understanding of antibody titers in relation to reference ranges and clinical history. The table below outlines the typical parameters evaluated during this investigation:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-tTG IgG Antibody Level	Negative (Typically < 10 U/mL)	Positive (≥ 10 U/mL), indicating active celiac disease or gluten-sensitive enteropathy.
Total Serum IgA Level	Normal (Within age-specific reference ranges)	Deficient (< 0.2 g/L or < 7 mg/dL), confirming selective IgA deficiency.
Small Intestinal Mucosa (Inferred)	Intact villi, normal crypt-to-villi ratio, no significant intraepithelial lymphocytes.	Villous atrophy, crypt hyperplasia, and mucosal inflammation (Marsh Class I-III).
Gluten Exposure Status	No immune activation (if on a gluten-free diet) or normal tolerance (if on a regular diet).	Active autoimmune response triggered by ongoing gluten ingestion.
Nutritional Absorption Capacity	Normal absorption of iron, folate, calcium, and fat-soluble vitamins.	Impaired absorption leading to anemia, osteopenia, and vitamin deficiencies.
Clinical Symptom Correlation	Absence of gluten-related gastrointestinal or systemic symptoms.	Chronic diarrhea, abdominal pain, bloating, fatigue, or dermatitis herpetiformis.
Pediatric Growth Parameters	Normal growth, development, and weight gain according to age percentiles.	Failure to thrive, short stature, and delayed pubertal development.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Anti Tissue Transglutaminase IgG?

• Advanced Diagnostic Technology: Lahore PCR Lab utilizes state-of-the-art, automated immunoassay platforms that ensure high analytical sensitivity and specificity for serological testing.
• Expert Pathologist Supervision: All immunological assays are conducted under the direct supervision of highly qualified Consultant Pathologists, ensuring rigorous clinical oversight.
• Strict Quality Assurance: The laboratory adheres to stringent internal and external quality control protocols to deliver highly accurate and reproducible test results.
• Convenient Online Report Access: Patients can easily view, download, and share their diagnostic reports via a secure online portal and receive instant SMS notifications.
• Professional Phlebotomy Services: Highly trained and compassionate phlebotomists ensure a comfortable, hygienic, and virtually painless blood collection experience.
• Rapid Turnaround Time: Efficient laboratory workflows guarantee that accurate results are delivered promptly, facilitating timely medical decisions.
• Centrally Located Facility: Located conveniently in Lahore, the laboratory and its collection centers are easily accessible to patients from all parts of the city.
• Patient-Centric Care: Lahore PCR Lab is committed to providing an ethical, transparent, and supportive environment focused on patient well-being and diagnostic excellence.